Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_3
2
33%
Ph phase_2
1
17%
Ph phase_4
2
33%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 32 (33.3%)
Phase 42 (33.3%)

Trials by Status

completed467%
recruiting117%
unknown117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_1

A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

NCT07628049
completedphase_2

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

NCT05960097
completedphase_3

To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

NCT06177249
completedphase_4

Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza

NCT01693380
unknownphase_4

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

NCT05397587
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07628049Phase 1

A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

Recruiting
NCT05960097Phase 2

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Completed
NCT06177249Phase 3

To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

Completed
NCT01693380Phase 4

Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza

Completed
NCT05397587Phase 4

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

Unknown
NCT04204096Phase 3

Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)

Completed

All 6 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
6